drugset / Trial / NCT01747083
Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)
RandomizedCrossoverOpen-label
Summary
This study is designed to investigate the food-effects on FDC(gemigliptin/metformin HCl sustained release) 50/1000mg(25/500mg x 2tablets)
Timeline
- Start
- 2013-01
- Primary completion
- 2013-03
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemigliptin | Small molecule | 50 mg | — |
| Subject | Metformin | Small molecule | 1000 mg | — |